scanX
Home
Wanbury

Wanbury

261.70
-13.59
(-4.94%)
Market Cap (₹ Cr.)
₹897
52 Week High
290.20
Book Value
₹
52 Week Low
70.40
PE Ratio
33.27
PB Ratio
40.86
PE for Sector
38.75
PB for Sector
4.65
ROE
%
ROCE
66.09 %
Dividend Yield
0.00 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
15.60 %
Net Income Growth
638.26 %
Cash Flow Change
-79.90 %
ROE
532.17 %
ROCE
659.53 %
EBITDA Margin (Avg.)
162.17 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
130
121
107
102
96
179
123
114
111
94
170
94
92
86
100
106
109
94
110
97
150
67
95
111
122
128
124
125
211
119
125
126
131
147
145
146
140
132
Expenses
117
105
97
98
91
92
109
107
109
103
156
86
96
86
96
100
94
86
94
89
75
70
86
96
122
121
117
116
122
120
118
119
119
133
127
124
121
120
EBITDA
12
16
10
3
5
86
14
7
2
-9
14
8
-4
-0
4
6
15
9
15
8
75
-3
9
15
-1
7
7
9
90
-1
6
7
12
14
18
22
19
12
Operating Profit %
3 %
12 %
8 %
2 %
5 %
3 %
10 %
5 %
-2 %
-10 %
-35 %
7 %
-32 %
-1 %
3 %
5 %
7 %
9 %
14 %
8 %
-12 %
-4 %
9 %
13 %
-1 %
5 %
6 %
7 %
10 %
-3 %
5 %
5 %
10 %
9 %
12 %
15 %
13 %
8 %
Depreciation
3
2
2
2
2
3
2
2
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Interest
9
10
10
8
5
10
8
8
9
8
8
7
7
6
6
6
22
7
8
7
10
6
5
6
6
5
5
6
5
3
4
7
8
6
8
8
7
8
Profit Before Tax
0
4
-2
-7
-2
73
3
-4
-10
-20
4
-2
-14
-9
-4
-2
-10
-1
5
-2
63
-11
2
6
-9
-1
-1
0
82
-7
-1
-3
1
5
7
10
8
1
Tax
1
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-0
4
-2
-7
-2
74
3
-4
-11
-20
4
-2
-13
-9
-4
-2
-10
-1
5
-2
62
-11
2
6
-9
-1
-1
0
83
-7
-1
-3
1
5
7
10
8
1
EPS in ₹
-0.11
2.23
-1.22
-3.50
-1.03
36.66
1.29
-2.27
-4.53
-8.46
1.52
-0.96
-5.58
-3.59
-1.79
-0.93
-4.17
-0.35
2.12
-0.90
26.02
-4.47
0.65
2.36
-3.58
-0.28
-0.17
0.12
25.62
-2.22
-0.27
-1.00
0.31
1.43
2.25
3.14
2.47
3,274.55
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
394
386
411
271
285
277
288
351
302
343
Fixed Assets
164
180
186
178
172
164
167
167
167
167
Current Assets
181
164
190
72
93
88
96
170
120
159
Capital Work in Progress
19
14
10
10
9
14
11
2
2
3
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
212
192
215
83
103
99
109
182
133
174
Total Liabilities
563
550
538
430
468
395
418
349
309
316
Current Liabilities
264
298
375
321
334
284
328
333
293
214
Non Current Liabilities
298
251
163
109
134
111
90
16
16
101
Total Equity
-168
-163
-127
-159
-184
-118
-131
2
-7
28
Reserve & Surplus
-188
-183
-151
-183
-207
-143
-156
-30
-40
-5
Share Capital
20
20
23
24
24
25
25
33
33
33
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
5
-5
3
-2
-0
-0
7
13
-21
2
Investing Activities
-5
-20
-13
-1
-3
64
8
1
-9
-17
Operating Activities
40
43
43
32
30
44
17
41
20
4
Financing Activities
-30
-28
-27
-33
-27
-108
-17
-29
-32
15
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Apr 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
52.09 %
39.93 %
39.90 %
39.90 %
39.89 %
39.89 %
39.85 %
39.85 %
39.84 %
39.84 %
39.84 %
39.80 %
39.79 %
39.79 %
39.79 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.18 %
0.22 %
DIIs
1.13 %
0.53 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.13 %
0.13 %
0.13 %
0.13 %
0.13 %
0.13 %
0.00 %
0.00 %
Government
0.00 %
1.04 %
0.00 %
0.00 %
1.04 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
46.78 %
58.50 %
60.09 %
60.09 %
59.07 %
60.11 %
60.15 %
60.02 %
60.03 %
60.03 %
60.03 %
60.07 %
60.08 %
60.03 %
59.98 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20
Biocon
370.65 43,587.78 27.93 15,621.20 35.25 1,298 478.78 51.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
56.28
ATR(14)
Volatile
13.96
STOCH(9,6)
Neutral
57.51
STOCH RSI(14)
Neutral
34.41
MACD(12,26)
Bearish
-0.79
ADX(14)
Strong Trend
38.35
UO(9)
Bearish
41.94
ROC(12)
Uptrend But Slowing Down
0.54
WillR(14)
Neutral
-48.99
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.